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Many environmental endocrine disrupting compounds act as ligands for nuclear receptors. 
Among these receptors, the human pregnane X receptor (hPXR) is well described as a 
xenobiotic sensor to various classes of chemicals including pharmaceuticals, pesticides and 
steroids. To assess the potential use of PXR as a sensor for aquatic emerging pollutants, we 
employed an in vitro reporter gene assay (HG5LN-hPXR cells) to screen a panel of 
environmental chemicals and to assess PXR active chemicals in (waste) water samples. Of the 
57 compounds tested, 37 were active in the bioassay and 10 were identified as new PXR 
agonists: triazin pesticides (promethryn, terbuthryn, terbutylazine), pharmaceuticals 
(fenofibrate, bezafibrate, clonazepam, medazepam) and non co-planar PCBs (PCB101, 138, 
180). Furthermore, we detected potent PXR activity in two types of water samples: passive 
polar organic compounds integrative sampler (POCIS) extracts from a river moderately 
impacted by agricultural and urban inputs and three effluents from sewage treatment works 
(STW). Fractionation of POCIS samples showed the highest PXR activity in the less polar 
fraction, while in the effluents PXR activity was mainly associated with the dissolved water 
phase. Chemical analyses quantified several PXR active substances (i.e. alkylphenols, 
hormones, pharmaceuticals, pesticides, PCBs, bisphenol A) in POCIS fractions and effluent 
extracts. However, mass-balance calculation showed that the analysed compounds explained 
only 0.03 % and 1.4 % of biological activity measured in POCIS and STW samples, 
respectively. In effluents, bisphenol A and 4-tert-octylphenol were identified as main 
contributors of instrumentally-derived PXR activities. Finally, the PXR bioassay provided 
complementary information as compared to estrogenic, androgenic and dioxin-like activity 
measured in these samples. This study shows the usefulness of HG5LN-hPXR cells to detect 
PXR active compounds in water samples, and further investigation will be necessary to 
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identify the detected active compounds. Keywords: Reporter bioassays, endocrine disrupters, 
passive sampling, wastewater. 
INTRODUCTION 
Anthropogenic activities lead to a continuous contamination of aquatic environment by a wide 
variety of chemicals. Among them, the so-called endocrine disrupting compounds (EDCs) can 
mimic or alter the action of endogenous hormones, through multiple mechanisms of action as 
they can interfere with the synthesis, transport, action, metabolism and excretion of natural 
hormones, which control homoeostasis, development and reproduction functions [1]. 
Abnormalities linked to EDCs exposure has been several times observed in aquatic 
environment, such as disrupted vitellogenin synthesis or development of ovo-testis in male 
fish [2]. In this context, characterization and identification of aquatic contamination by EDCs 
has become a major issue for the last decade. To tackle this challenge, the recent development 
of integrated bio-analytical approaches using in vitro bioassays combined to chemical 
analyses has proven powerful methodology to detect and identify bioactive compounds within 
complex environmental samples [3]. Particularly, in vitro reporter gene bioassays based on 
the mechanisms of action of chemicals (e.g. hormone receptor activation) serve as screening 
tools for sensitive and specific detection of hormone-like activities in complex samples. 
To date, in vitro bio-analytical assessment of EDCs has mainly concerned estrogen receptor 
(ER) and androgen receptor (AR) mediated activities [4-6]. However, these bioassays do not 
take into account large diversity of EDCs since several emerging contaminants, such as some 
pharmaceutical compounds, are not ligands of these receptors. Apart from ER and AR, other 
key nuclear receptors (NRs) such as pregnane X receptor (PXR) [7], peroxisome proliferator-
activated receptor (PPAR) [8] or glucocorticoid receptor (GR) [9], are known to be directly 
activated by environmental contaminants, and thus can be potentially used as xenobiotic 
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sensors for environmental bio-analytical purpose. Among them, the PXR, also called steroid 
and xenobitic receptor (SXR) or pregnane activated receptor (PAR), is of high interest for 
such purpose since it has been shown to be activated by a diversity of environmental ligands 
such as steroids, pharmaceuticals, pesticides, alkylphenols, polychlorobiphenyls (PCBs) and 
polybromodiethylethers (PBDEs) [10-17].  
The PXR is an orphan NR because no endogenous ligand with high affinity has been 
identified so far [18]. As a nuclear receptor, PXR acts as a transcription factor. After ligand 
binding, it functions as an heterodimer with the retinoid X receptor (RXR), in a non 
permissive way [19]. It is mainly expressed in the liver and the intestine, the main organs 
involved on the metabolism of endogenous and exogenous compounds, where it plays a 
crucial role in the regulation of genes involved in xenobiotic detoxification. PXR controls the 
transcription of phase I cytochrome P450 (CYP) genes (e.g. CYP3A4, -2B6, -2C8, -2C9 and -
2C19), phase II conjugating enzymes (e.g. UDP-glucuronosyltransferases and glutathion-S-
transferase), as well as phase III transporter genes (e.g. MDR-1 and MRP-2 multidrug 
resistance proteins) [20]. In addition, PXR is also activated by endogenous ligands, notably 
bilary acids, pregnanes and hormones and thereby regulates the transcription of CYP7A and 
oatp2 transporter involved in cholesterol homeostasis and tissue protection from potent toxic 
endogenous compounds [21]. Overall, the essential biological role in both xenobiotic and 
endogenous metabolism regulation together with its ability to directly interact with various 
environmental chemicals make the PXR a toxicologically and environmentally relevant target 
for EDCs. 
The aim of this study was to explore the potential use of a recently described human PXR 
(hPXR) reporter gene bioassay [12] for the detection of EDCs in the aquatic environment. 
This in vitro bioassay is based on cultured HeLa cells that permanently express the luciferase 
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reporter gene under the control of a chimeric hPXR (HG5LN-hPXR cells), and has been 
shown to sensitively respond to several pesticides [12], as well as antiestrogens, 
mycoestrogens and phthalates [14]. In the present study, in order to characterize the activity 
of a broader range of environmental contaminants, more than 60 environmentally occurring 
chemicals including pharmaceuticals, pesticides, plasticizers and persistent organic pollutants 
(POPs) were tested in this in vitro system. In addition, the detection of hPXR ligands in 
different effluent samples and polar organic compound integrative samplers (POCIS) extracts 
from freshwater sites has been investigated. The detected biological responses were compared 
to targeted chemical analyses by using mass balance calculation in order to identify candidate 
hPXR ligands in active samples. 
 
MATERIALS AND METHODS  
Chemicals and reagents 
All standard chemicals listed in Tables 1-3 were purchased from Sigma Aldrich (St Quentin-
Fallavier, France), except PCB congeners that were from LGC standards (Molsheim, France). 
Luciferin, 3-(4,5-dimethylthiazol-2-ol)-2,5-diphenyltetrasodium bromide tetrazolium (MTT), 
methanol (MeOH) and dimethylsulfoxide (DMSO) were also purchased from Sigma-Aldrich 
(St Quentin Fallavier, France). 
In vitro bioassays  
Cell culture  
The HG5LN-hPXR cell line results from a two-step stable transfection [12]. As a first step, 
Hela cell were stably transfected with a GAL4RE5-BGlob-Luc-SVNeo plasmid, leading to 
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the HG5LN cell line which expresses constitutively luciferase activity. Then, HG5LN cells 
were stably transfected, with the pSG5-GAL4(DBD)-hPXR(LBD)-puro plasmid to obtain the 
HG5LN-hPXR cell line. The HG5LN cell line was used to assess toxic or unspecific effects 
on luciferase in the bioassay, hence providing information on the specificity of hPXR 
activation in HG5LN-hPXR cells. 
Both cell lines were routinely cultured in a 5 % CO2 humidified atmosphere at 37°C in 
Dulbecco’s Modified Eagle’s Medium (DMEM) containing phenol red (Sigma-Aldrich, St 
Quentin Fallavier, France) and supplemented with 5% fetal calf serum (FCS), 1% 
nonessential amino acids, penicillin/streptomycin (50 U/mL each) and 1 mg/mL G418 (all 
purchased from Invitrogen, Cergy Pontoise, France). Additionnaly, 0.5 µg/mL puromycin was 
added in HG5LN-hPXR cell medium. 
Luciferase assay 
The cells were seeded in 96-well white opaque culture plates (Greiner cellStar ; D. Dutscher, 
Brumath, France) at a density of 1 x 10
5
 cells per well in 100 µl of DMEM without phenol 
red, supplemented with 6% dextran-coated charcoal-treated fetal calf serum (DCC-FCS). 
After 24 h, a range of concentration of compounds to be tested was added to the culture 
medium in triplicates and cells were then incubated for 16 h. For environmental samples, cells 
were exposed to serial dilution of extracts. At the end of exposure, the medium was removed 
and 50 µl per well of medium containing 0.3 mM luciferin were added. Five minutes later, 
necessary for luciferin to diffuse into the cell and to produce a stable luminescence signal, the 
intact living cells luminescence was measured in for 2 seconds per well with a microtiter plate 




In order to assess the effect of test compounds on cell viability in HG5LN-hPXR cells, the 
metabolism of 3-(4.5-dimethyl-thiazol-2-yl)-2.5diphenyl tetrazolium bromide (MTT), was 
measured. After luciferase assay, culture medium containing the luciferin was removed and 
replaced by 100µl of DCC-FCS with 0.5 mg/mL of MTT. Cells were incubated for 3h. In 
metabolically active cells, MTT is reduced by the mitochondria onto a blue formazan 
precipitate, which was solubilised by adding 80 µl of isopropanol and agitation for 30 min. 
Plates were then read at 570 nm against a 640 nm reference wavelength on a microplate 
reader (KC-4, BioTek Instruments, France). Cell viability was expressed as a percentage of 
the control value. By using the MTT assay, no significant cytotoxic effects of chemicals were noted 
at the concentrations tested in luciferase assays. 
Other in vitro bioassays 
The estrogenic, (anti-)androgenic and dioxin-like activities of the extracts were assessed by 
using three in vitro bioassays based on marker gene activation in the MELN, MDA-kb2 and 
PLHC-1 cell lines, respectively. The MELN cells consist of the human MCF-7 cells that were 
stably transfected by the luciferase reporter gene controlled by endogenous estrogen receptor 
alpha (ER ) [22]. The MDA-kb2 cell line (ATCC, #CRL-2713) was derived from the MDA-
MB-453 human breast cancer cells. They were stably transfected by a MMTV promoter-
luciferase plasmid construct, which is under the control of endogenous androgen receptor 
(AR) and glucocorticoid receptor (GR) [23]. The fish hepatic PLHC-1 cell line (ATCC, 
#CRL-2406) was described by Ryan and Hightower [24]. Protocols for routine cell culture 
and environmental sample assessment has been reported in details previously [25]. Briefly, in 
the MELN and MDA-kb2 bioassays, cells were exposed for 16 h and processed for luciferase 
activity assay as described above. In the PLHC-1 bioassay, cells were exposed for 4 h (PAH-
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like activity) and 24 h (dioxin-like activity) and were then processed for 7-ethoxyresorufin-O-
deethylase (EROD) activity assessment in intact cells.  
Environmental samples 
Wastewater effluents 
Three sewage water effluents (SWE), called A, B and C, were sampled in the South West of 
France at three different stations: effluent A was a paper mill effluent; effluent B was sampled 
at the outlet of an urban wastewater treatment plant which serves a catchment of about 
150,000 equivalent/inhabitant population equivalent, and ensured the treatment of mainly 
domestic sewage; effluent C was a mix of sewage effluents A and B.  
Effluent extracts were prepared as summarized in figure 1. Briefly, a part of each effluent was 
filtered on GFF filters immediately after collection. Then, liquid/liquid extractions were 
performed on both the filtered fraction and the crude fraction of each effluent (A, B and C). A 
volume of 250 mL of each fraction was extracted 3 times by shaking with 50 mL of 
dichloromethane. The total extract was dried with anhydrous sodium sulfate. It was 
concentrated with a rotary evaporator, and then under a gentle flow of nitrogen and 
transferred into 200 µL of methanol. Procedural blank using ultra pure water was also 
prepared in the same conditions in order to test the potential influence of the extraction 
process on bioassay responses. Each extract was used for bioassay and chemical analyses. 
 
POCIS extracts 
POCIS samplers (version for sampling pharmaceuticals) were deployed in May 2007 in the 
Baïse River (South West of France) during 1 month. This site is under mixed anthropogenic 
pressures and is classified as good quality water. POCIS were provided by Exposmeter 
(Tavelsjö, Sweden). They contain 200 mg of Oasis HLB sorbent enclosed between two 
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polyethersulfone (PES) membranes. The membranes, which confine the sorbent, are 
compressed between two metal disks (5.1 cm ID, 8.9 cm OD). The total exchanging surface 
area of the membranes is 41 cm2. The ratio surface area to mass of sorbent is about 200 cm2/g. 
After exposure, each POCIS was rinsed with ultra pure water to remove any material present 
on the outer surface of the membranes (particles and biofilms). The metal disks were 
disassembled and the membranes were detached from the disk. The sorbent was carefully 
transferred into an empty glass SPE tube by rinsing it with ultrapure water and then dried by 
applying vacuum for 1 hour. The organic compounds were eluted in 3 fractions: a first 
fraction (F1) of 10 ml of dichloromethane, a second fraction (F2) of 10 ml of a 
dichloromethane - methanol mixture (50:50 v/v) and a third one (F3) of 10 ml of methanol. 
After elution, extracts were evaporated to complete dryness and dissolved in 200 µl of 
methanol. Each of the three fractions was assessed by bioassays and chemical analyses.  
 
Chemical analysis  
Pharmaceuticals, alkylphenols, and a part of pesticides (phenylurea herbicides) were analyzed 
by LC/MS/MS. PAHs, hormones and remaining pesticides (triazines, organophosphate and 
pyrethrenoid pesticides) were analyzed by GC/MS. PCBs and organochlorinated pesticides 
were analysed by GC/ECD. The analytical procedures were adapted from Togola and 
Budzinski [26] for the pharmaceuticals, Labadie and Budzinski [27] for the hormones, 
Budzinski et al. [28] for the PAHs, Alder et al [29] for the pesticides, Cailleaud et al [30] for 
the PCBs and Cailleaud et al [31] for the alkylphenols. Hydrophilic compounds 
(pharmaceuticals, phenylureas, triazines, organophosphate and pyrethrenoid pesticides) have 




Bioassay data modeling  
The Regtox 7.5 Microsoft Excel
TM
 macro, freely available at http://eric.vindimian.9online.fr, 
and using the Hill equation [32], was used to model sigmoid dose-response curves and to 
calculate efficient concentrations (i.e. EC20 and EC50, corresponding to concentrations of 
chemical and samples that induced 20 and 50% of maximal luciferase activity, respectively). 
For compounds that provided incomplete dose responses curves, i.e. that does not reached a 
plateau, the Hill parameter for maximal effect was fixed at 100% (maximal response given by 
the positive control SR12813) before modelling of the data. 
Mass balance calculations 
Toxic equivalent activities derived from chemical analysis (Chem-TEQ) in environmental 
samples were calculated according to the following equation: TEQ = ∑ (Ci × SREFi), where, 
for a given chemical i, Ci is the measured concentration in a sample and SREFi is the inducing 
equivalent factor relative to the reference ligand SR12813 (IEFi = EC20 of reference 
compound / EC20 of test compound, on mass basis) and expressed as SR12813-equivalent 
quantities (SREQ). SREFi were determined by establishing dose-response curves for 
individual standard chemicals according to the criteria proposed by Villeneuve et al [33] (i.e. 
parallel dose response curves and equal efficacy). Thus, for all compounds, including those 
with incomplete dose response curves, we fixed the minimal and maximal activity and the 
slope as identical to that of SR12813 before modelling of experimental data (data not shown). 
The biological toxic equivalent activities (Bio-TEQ) in environmental samples were 
calculated as the ratio of EC20 of reference compound (expressed as g/L) to that of the sample 
expressed as EQ-L water/L (equivalent litre of water sample per litre). For the samples that 
yielded incomplete dose response curves, we fixed the minimal and maximal activity and the 
slope as identical to that of SR12813 for experimental data modelling. Although fixed-effect 
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level modelling often assumes an extrapolation of experimental data, it allows standardised 
treatment of all data and thus EC20 comparison between samples and reference compounds. 
Statistics 
Significant luciferase induction in treated cells as compared to solvent treated cells was 
determined by one way analysis of variance (ANOVA) followed by a Dunnett’s unilateral 
posthoc test. A value of p < 0.05 was considered significant. 
 
RESULTS  
Activation of hPXR by reference and environmental chemicals 
In order to validate the use of the hPXR bioassay in our experiments, four reference hPXR 
ligands were first tested (Fig. 2). They induced potent and complete dose-response curves 
with sensitivities that were very similar than those previously reported in the same cell model 
[12]. The specific hPXR-mediated activity by these ligands was confirmed by a lack of effect 
on luciferase expression in the parental HG5LN cell line that does not express hPXR (Fig 2b). 
These cells were then further used to assess the activity of a panel of about 60 compounds that 
belong to different classes of contaminants. In each group of compounds, some chemicals, 
which PXR activity has been previously reported in this or other cell model, were also 
assessed in order to determine their hPXR potency in our test conditions. 
Activation of hPXR by pesticides 
Sixteen pesticides from different classes (organochlorine, triazin, urea) were screened (Tab. 
1). Oxadiazon, pretilachlore, o,p’-DDT and linuron activated the luciferase with the same 
induction pattern (i.e. in terms of affinity, maximal activity and specifity) as previously 
reported by Lemaire et al. [12] by using the same cell line (Fig. 3 and Tab. 1). The 
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organochlorine lindane and endosulfan were strong hPXR activators in HG5LN-hPXR cells, 
while triclosan, terbutylazine, terbuthryn and promethryn were found as weak to moderate 
hPXR activators (Fig 3a). Moreover, terbutylazine, terbuthryn and promethryn, could be 
considered as specific hPXR activators since they did not alter luciferase expression in 
HG5LN cells, whereas triclosan was slightly toxic in this cell line as indicated by a decrease 
of luciferase (Fig 3b). Finally TBT, chlorotoluron, metoxuron, chlorosulfuron, nicosulfuron 
and hexachlorobenzene were found as inactive compounds (Tab. 1). 
Activation of hPXR by pharmaceuticals 
Studies on in vitro hPXR transactivation by environmental pharmaceuticals are scarce. Here, 
we have tested hPXR activation by 21 compounds that were selected among those commonly 
found in surface waters (Tab. 2). Ten out of 21 environmental pharmaceuticals were specific 
hPXR activators in HG5LN-hPXR cells (Fig 4a, Tab. 2), with induction patterns varying 
according to effective concentration and maximal levels of luciferase induction. Mevastatin 
and fenofibrate were the most potent hPXR activators as they induced more than 60% of 
luciferase activity at 10 and 3 µM, respectively. Diclofenac, tamoxifen, medazepam, 
carbamazepin, triazolam, diazepam, clonazepam, and bezafibrate were weak to moderate 
hPXR activators as they induced partial dose-response curves at relatively high concentrations 
(3 to 100 µM) (Fig. 4a, Tab. 2). Ketoprofen also slightly induced luciferase at 100 µM; 
however luciferase induction by this compound is likely to be non specific of the hPXR as it 
similarly occurred in HG5LN cells (Fig 4b). Finally, loprazolam, bromazepam, alprazolam, 
naproxen, ibuprofen, aspirin, caffein, flumazemil, pravastatin and sulfamethoxazole were 
found inactive in HG5LN-hPXR cells (Tab. 2). 
Activation of hPXR by POPs 
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Because of the ubiquitous character of PCBs and PAHs as environmental contaminants, we 
looked at hPXR activation by 10 dioxin-like and non dioxin-like PCBs and 4 toxic PAHs. 
Strong luciferase induction was observed with the non dioxin-like PCBs congeners #101, 138, 
153 and 180, albeit at relatively high concentrations (EC50s > 10 µM) (Fig. 5a, Tab. 3). In 
HG5LN cells, PCB101, PCB153 and PCB180 were also able to slightly increase luciferase 
(i.e. by two-fold for PCB101), thus suggesting that a small part of their induction potency in 
HG5LN-hPXR was due to non specific activation of luciferase at high concentrations (Fig. 
5b). PCB118 was found to weakly increase luciferase in both HG5LN-hPXR and HG5LN 
cells and thus should not be considered as an hPXR activator (Fig. 5). Finally, the other PCBs 
#28, 77, 126 and 169 as well as the 4 PAHs tested, i.e. benzo[k]fluoranthene, fluoranthene, 
naphtalene, and 3OH-benzo(a)pyrene, were unable to activate the hPXR after a 24 h exposure 
at concentrations up to 1 µM (Tab. 3).   
Activation of hPXR by other compounds 
Other emerging pollutants, including parabens, antioxidants and plasticizers, were tested 
(Tab. 3). Among them, triphenyl phosphate (TPP), which is used as plasticizer and fire 
retardant, induced partially (Fig. 5a) but specifically (Fig 5b) the hPXR. Conversely, no effect 
was noted with parabens and butylated hydroxytoluene (BHT). 
 
Detection of hPXR activities in environmental samples 
In order to assess the environmental occurrence of hPXR ligands in surface waters, the hPXR 
bioassay was applied to different water samples issued from a contaminated river (POCIS 
extracts) and three sewage water effluents. 
Activation of hPXR by POCIS extracts 
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POCIS samplers were deployed for 1 month in the Baïse River, which is under agricultural 
and urban pressure, and were then extracted and fractionated onto 3 fractions of increasing 
polarity (F1, F2, F3), as described in Material and Methods. Biological analysis showed that, 
among the 3 fractions, F1 and F2 expressed a PXR activity (Fig. 6a), whereas protocol blanks 
were inactive (data not shown). F1 and F2 gave an incomplete dose response curve with the 
highest activation for F1 (61 ± 4 %) and a moderate activation for F2 (38 ± 1 %) (Fig. 6a). In 
HG5LN cells, no significant alteration of luciferase activity was noted (Fig. 6b). These results 
show that POCIS extracts contained specific hPXR ligands that were likely to be semi-polar 
rather than polar compounds (i.e. hormones). 
Targeted chemical analyses of POCIS fractions showed the presence of PXR ligands such as 
several pharmaceuticals compounds, pesticides, alkylphenols and hormones. The table 4 
summarizes those chemicals that were identified as hPXR ligands among all chemicals 
analysed; a detailed analytical evaluation of these samples has been reported elsewhere ([34] 
and Tapie et al, in prep). On the basis of SR12813-Equivalent Factors (SREF) for individual 
compounds determined in the present study, instrumentally derived SR12813-equivalents 
(Chem-SR-EQ) were calculated and compared to SR-EQ determined by the bioassay (Bio-
SR-EQ). The results (Tab. 4.) showed that, on an additive model basis, the targeted 
compounds weakly contributed (<0.1%) to Bio-SR-EQs in the samples and the detected PXR 
activities were likely due to other non analysed compounds. 
Activation of hPXR by effluent extracts 
All three effluent samples induced significant activation of luciferase activity in a dose-
dependent (Fig. 7a) and specific (Fig. 7b) manner. Procedural blanks were inactive in 
HG5LN-hPXR cells (data not shown). The paper mill effluent (site A) was the most active 
site, followed by the mixed industrial/urban effluent (site C) and then by the urban effluent 
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(site B). When comparing the response of crude effluent extract to that of filtered effluent 
extracts, no significant difference could be noted on hPXR activation, suggesting that the 
detected compounds were associated with the soluble phase of the samples. Only a toxic 
effect was noted for the crude extract of site A (sample A-c in Fig 7), which led to a decrease 
of luciferase activity at higher sample concentrations (not illustrated).  
Targeted chemical analyses of the samples showed the occurrence of several compounds that 
were hPXR ligands such as pharmaceuticals, hormones, pesticides, PCBs, bisphenol A (BPA) 
and 4-tert-octylphenol (4tOP) (Tab. 5). Mass balance calculation showed that the quantified 
chemicals explained only a few part of the biological activity determined by the bioassay 
(0.13-1.42%). Nevertheless, it was noted that BPA, which was among the most abundant 
contaminants, contributed to more than 95 % of the total Chem-SR-EQs at sites A and C, and 
to 10 % at site B. In this later site, an urban one, 4tOP contributed to more than 62 % of the 
calculated Chem-SR-EQs. Pharmaceuticals, hormones and pesticides (i.e. diuron and linuron) 
were also present at significant concentrations in the urban and mixed effluent (sites B and C), 
but they were identified as minor contributors to the Chem-SR-EQs. Moreover, effluent 
filtration had very low influence on Chem-SR-EQ determination, which confirmed the 
biological assessment and strengthened the hypothesis that the detected PXR ligands were 
mainly present in the dissolved phase. However, except for BPA and 4tOP, the compounds 
that mainly contributed to biological activities remain to be identified.  
Comparison with ER, AR and AhR activities 
To get further knowledge of the contamination of the samples by EDCs, we measured 
estrogenic, (anti)androgenic and AhR activities by using in vitro bioassays and compared 
them with hPXR activity (Tab. 6). In POCIS fractions, estrogenic and PAH-like activities 
were mainly detected in F1 and to a lesser extent in F2, yielding the same elution pattern as 
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hPXR activities. No (anti)androgenic or TCDD–like activity was detected in the three POCIS 
fractions. In effluents samples, ER and PAH-like activities were detected in all samples while 
a significant AR activity was also present at site C (Tab. 6.). Effluent filtration had either no 
influence at site A or enhanced ER and AR activity at sites B and C, thus showing that the 
detected active substances were in the soluble phase. Conversely, PAH-like activities were 
higher in crude than in filtered samples suggesting that the detected chemicals were mainly 
associated with the particulate fraction. Unlike POCIS fractions, profiles of ER activities in 
effluent samples differed from patterns of PXR responses, i.e. in a decreasing order, for 
estrogenic activity: site C > site B > site A, whereas for PXR activity: site A > site C >> site 
B. These results suggest that different chemicals were detected by the two bioassays, and 




By using a recently developed stable reporter gene bioassay, we report i) the characterization 
of the hPXR transactivation potency of a large panel of environmental chemicals, including 
emerging pollutants that were not tested before, and ii) the occurrence of hPXR ligands in 
effluents and surface water samples. 
hPXR is activated by various chemicals occurring in aquatic environment 
Of the 53 substances tested on HG5LN-hPXR cells, 37 were found active and 10 were 
identified as new hPXR agonists. These include three triazin pesticides (prometryn, terbutryn, 
terbutylazine), four pharmaceuticals (fenofibrate, bezafibrate, clonazepam, medazepam) and 
three PCB congeners (PCB 101, 138 and 180).  
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Pesticides and human pharmaceuticals were selected as relevant emerging contaminants that 
are increasingly detected in surface waters. Several pesticides have been described as potent 
PXR activators, among which organochlorinated pesticides, chloroacetanilides, pyrimidines 
and azoles fungicides were the most active ones [12,35]. In complement to these previous 
studies, we report here three triazin pesticides as hPXR modulators in HG5LN-hPXR cells. 
These triazin pesticides are widespread aquatic contaminants and among the most frequently 
detected pesticides in surface waters [36,37]. Accordingly, they were also detected in POCIS 
extracts from the Baïse River in the present study (Table 4). 
A number of human pharmaceutical drugs have been described as CYP3A inducers through 
their capacity to bind and activate PXR [15]. Ten out of 21 compounds tested were found to 
partially but specifically activate hPXR in HG5LN-hPXR cells. Some of them such as 
tamoxifen [10], mevastatin [38] and carbamazepin [17] have previously been described as 
PXR ligands. Our data confirmed their activity and depicted their potency in our bioassay. 
Moreover, to our knowledge, the cholesterol-lowering drugs fenofibrate and bezafibrate and 
the benzodiazepines medazepam and clonazepam were here newly described as hPXR 
ligands. For fibrates, Prueksaritanont et al [39] reported a lack of hPXR transactivation by 
fenofibric acid, the metabolite of fenofibrate, in HepG2 cells transfected with a Gal-
PXR/luciferase system. To some extent, this partly contrasts with our results with fenofibrate, 
the parent compound however, which activated the hPXR at micromolar concentrations.  
Finally, diclofenac, a non-steroidal anti-inflammatory drugs (NSAID) usually found in the 
aquatic environment [40], was also active on hPXR, in agreement with a recent report [15]. 
Besides, it is noted that 11 of the tested drugs, including environmentally recurrent ones (e.g. 
caffeine), were not active in the assay, hence showing some limitation of the bioassay as a 
biodetector for pharmaceuticals. Overall, our data on hPXR activation by various classes of 
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pesticides and environmental pharmaceuticals confirm its potential use as a sensor for certain 
emerging aquatic contaminants.  
Previous studies pointed out the ability of nonplanar PCBs to bind and activate or inhibit PXR 
from different species [11,16,41]. Accordingly, we observed that nonplanar PCBs but not co-
planar PCBs were hPXR ligands, although some discrepancies with previous studies were 
noted. By using a transient Gal-hPXR reporter gene assay, Tabb et al. [16] described several 
highly chlorinated PCBs as very weak hPXR agonists and as potent hPXR antagonists, 
especially for congeners #153, 145, 184 and 197. In contrast, we found that nonplanar PCBs 
with more than five chlorine substituents (PCBs #101, 138, 153 and 180) were potent hPXR 
activators (Fig. 5), but they were unable to antagonize hPXR in HG5LN-hPXR cells after co-
exposure with 0.1 µM SR12813 (data not shown). Our results are however in agreement with 
other published studies reporting the agonistic effect of non planar PCBs on mouse (i.e. for 
PCB #47, 184, 188, 196, 200 [41]) and human PXR (i.e. for PCB #118, 153 [11]) in transient 
hPXR transactivation assays. For PCB118 however, we strongly suspected unspecific 
luciferase activation in both HG5LN-hPXR and HG5LN cells, hence we ranked this 
compound as a negative compound. Altogether, the ability of non co-planar PCBs to interfere 
with hPXR, here reinforced by our new results with PCB101, 138 and 180, stresses the view 
that such a PXR bioassay could serve as a biodetector for non dioxin-like PCBs in 
environmental bio-analysis. 
Among the other emerging EDCs tested, we notably report TPP as a relatively potent active 
chemical on HG5LN-hPXR cells, in accord with a previously published work [42]. TPP 
belongs to high-production-volume organophosphate esters (OPEs) widely used as flame 
retardant and plasticizers in several applications. OPEs are widespread water and air, 
sediment and soil contaminants [43]. Recently, TPP was shown to bioaccumulate in aquatic 
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organisms such as molluscs (mussels, oysters, clams) at concentration up to 378 ng/g dry wt 
[44] and environmental risk assessment for this substance is of current concern [45].  
Overall, the chemical screening carried out in the present study complemented previous 
studies performed with HG5LN-hPXR cells [12,14] in that it further characterized and 
extended to various structurally different contaminants the range of chemicals to be detected 
by this bioassay. In a bioanalytical perspective, establishment of dose-response curves for 
each individual compound allowed determining their relative potency as SR12813 equivalent 
factors (SREF) essential for mass balance calculation in the bioanalysis of environmental 
samples. This has been investigated in the second part of the study. 
HG5LN-hPXR cell line as a biosensor for the detection of emerging compounds in 
environmental matrices? 
To our knowledge, this is one of the first reports of the biological detection of PXR activating 
substances in surface water (POCIS) and effluent samples. Although we did not identify the 
nature of major chemicals responsible for the detected activities, mid-polar compounds in the 
dissolved water phase from both river and effluent samples could be suspected. In addition, 
the comparison of PXR activity with other receptor-mediated activities suggested that the 
PXR bioassay provided different information on chemical contamination, likely related to 
different detected compounds, and was thus complementary to the other assays within such a 
multi-tests battery (Tab. 6). 
By using the same in vitro model as in the present study, very recent studies reported the 
detection of PXR activities in wastewaters [46,47],  and river sediments from contaminated 
areas [48]. In these studies, instrumental analyses of target chemicals, including alkylphenols, 
steroid estrogens or organochlorinated pesticides, did not permit to identify the active 
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chemicals responsible for the PXR activity. Moreover, recent studies reported induction of 
Cyp3A expression by municipal effluents in cultured trout hepatocytes in vitro [49] or in 
zebrafish liver in vivo [50]. In the study of Lister et al., PXR mRNA expression in zebrafish 
was not affected after effluent exposure. In any case, the substances responsible for biological 
activities were not identified.  
Altogether, these results clearly show that chemical agents that can affect the PXR signaling 
pathway are present in the aquatic environment. Due to the important role of PXR in 
endocrine and xenobiotic metabolism regulation, identification of these agents is an important 
issue to be addressed. For such purpose, application of mass balance analysis (MBA) based 
on targeted chemical analyses coupled to in vitro bioassays has proven useful as a first 
characterization step of the chemicals responsible for biological effects, provided that 
significant information background on environmental levels of bioactive substance is 
available. For instance, by targeting steroid estrogens or PAHs, MBA approach has often 
succeeded in characterizing, at least partly, the chemicals responsible for “classical” activities 
such as ER or AhR activity, respectively [48,51,52]. For PXR activity however, such an a 
priori based investigation failed in identifying the main substances responsible for PXR 
activities in our study. Only BPA and 4tOP were shown to weakly contribute to overall PXR 
activity in wastewater effluent samples, while the other analyzed substances known to activate 
hPXR, including pharmaceuticals, planar PCBs or pesticides, were present at too low 
concentrations to significantly account for the measured biological activities.  
Several hypotheses can be advanced to explain the lack of concordance between biological 
and chemical analyses. The most probable cause is that we did not target the “good” 
chemicals by the chemical analyses. As a matter of fact, PXR can be activated by a wide 
diversity of known (and likely unknown) environmental compounds [53], and it is technically 
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impossible to perform exhaustive analyses. For instance, it is noted that some strong PXR 
activators like mevastatin, clotrimazole, pretilachlor or oxadiazon could not be measured in 
our samples. Moreover, the serious lack of data on the environmental occurrence of PXR 
active substances makes difficult a priori based investigation, as stated above. On the other 
hand, the mass balance approach we used assumes a concentration additive model, based on 
parallel dose-response curves and equal efficacy of chemical agonists [33]. It is noteworthy 
that some of the individual chemicals that we tested behave as partial PXR agonists (e.g. 
clotrimazole, mediazepam, oxadiazon, TPP) and it can be expected that other than additive 
interactions may occur when they are present in complex mixtures, hence impeding PXR 
activity prediction on the basis of individual potency of measured active compounds. 
Moreover, hPXR has a large and flexible ligand binding domain, allowing the binding of a 
wide range of structurally different ligands with molecular weights ranging from less than 250 
kDa to more than 800 kDa [19,54]. Thus, its smooth binding pocket could host several ligands 
at the same time, which might result in synergic response. However, to our knowledge, 
interactive effects of chemical mixtures on PXR activation has not been reported so far, and 
would thus be an important issue to be addressed within the context of the present study. 
Overall, this study should be considered as an exploratory study and further research will be 
necessary to identify PXR active chemicals in environmental samples. This will go through 
the implementation of effect-directed analyses coupled to dedicated sample fractionation 
protocols [55]. Also, the development of nuclear receptor-affinity columns [56], based on 
recombinant hPXR, represents a promising way to isolate and purify hPXR ligands from 
complex mixtures. These approaches are under evaluation in our laboratories and are expected 





In this work, we report the successful use of the stable HG5LN-hPXR reporter gene assay to 
detect hPXR activation by a panel of emerging compounds and by surface and waste water 
samples, albeit the main compounds that contributed to the detected activities remain to be 
identified. Combined to other in vitro bioassays for EDCs and AhR activating chemicals, the 
hPXR assay provided complementary information on bioactive contaminants and thereby 
enhanced the environmental diagnostic. As PXR plays a crucial role in xenobiotic 
detoxification and hormone metabolism, alteration of PXR signaling pathway may lead to 
biological effects in exposed organisms, as recently reported in fish [50]. However, marked 
cross-species differences have been reported for PXR transactivation by xenobiotics [57]. 
Thus, for a proper risk assessment to aquatic organisms, the use of a dedicated fish PXR 
bioassay to characterize potential hazard to fish population may also be considered. 
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Fig. 1 Schematic presentation of the preparation of effluent extracts and in vitro testing using 
bioassays.  
Fig. 2 (a) Dose-response curves of reference compounds in HG5LN-hPXR cells. Results are 
expressed as percentage of maximal luciferase activity induced by SR12813 at 3 µM. (b) 
Specificity test for luciferase induction in HG5LN cells. Results are expressed as percentage 
of luciferase activity measured in DMSO treated cells (solvent control). Values are means of 
triplicates ± SD and are representative of at least three independent experiments 
Fig. 3 (a) Dose-response curves of several pesticides in HG5LN-hPXR cells. Results are 
expressed as percentage of maximal luciferase activity induced by SR12813 at 3 µM. (b) 
Specificity test of luciferase induction by pesticides in HG5LN cells. Results are expressed as 
percentage activity measured in the presence of DMSO (solvent control). *: Significantly 
different from solvent control in HG5LN cells (p<0.05). In HG5LN-hPXR cells, all values are 
significantly different from control (p<0.05). Values are means of triplicates ± SD and are 
representative of at least three independent experiments 
Fig. 4 (a) Dose-response curves of pharmaceuticals compounds in HG5LN-hPXR cells. 
Results are expressed as percentage of maximal luciferase activity induced by SR12813 at 3 
µM. (b) Specificity test of luciferase activity induction by pharmaceuticals in HG5LN cells. 
Results are expressed as percentage activity measured in the presence of DMSO (solvent 
control). *: Significantly different from solvent control (p<0.05). In HG5LN-hPXR cells, all 
values are significantly different from control (p<0.05). Values are means of triplicates ± SD 
and are representative of at least three independent experiments 
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Fig. 5 (a) Dose-response curves of TPP and non co-planar PCBs in HG5LN-hPXR cells. 
Results are expressed as percentage of maximal luciferase activity induced by SR12813 at 3 
µM. (b) Specificity test of luciferase activity induction by TPP and non co-planar PCBs in 
HG5LN cells. Results are expressed as percentage activity measured in the presence of 
DMSO (solvent control). *: Significantly different from solvent control (p<0.05). In HG5LN-
hPXR cells, all values are significantly different from control (p<0.05). Values are means of 
triplicates ± SD and are representative of at least three independent experiments 
Fig. 6 (a) Dose-response of POCIS extracts in HG5LN-hPXR cells. Results are expressed as 
percentage of maximal luciferase activity induced by SR12813 at 3 µM. (b) Specificity test of 
luciferase activity induction by POCIS extracts in HG5LN cells. Results are expressed as 
percentage activity measured in the presence of DMSO (solvent control). *: Significantly 
different from solvent control (p<0.05). In HG5LN-hPXR cells, all values are significantly 
different from control (p<0.05). Values are means of triplicates ± SD and are representative of 
at least three independent experiments 
Fig. 7 (a) Dose-response curves by organic extracts of crude (-c) or filtered (-f) effluents A, B 
and C in HG5LN-hPXR cells. Results are expressed as percentage of maximal luciferase 
activity induced by SR12813 at 3 µM. (b) Specificity test of luciferase activity induction by 
effluents extracts in HG5LN cells. Results are expressed as percentage activity measured in 
the presence of DMSO (solvent control). Values are means of triplicates ± SD and are 





Table 1. Summary of hPXR activation by pesticides in HG5LN-hPXR cells.  
 









 5.31 E-07  68 ± 2 3  
compounds Pretilachlore 
b








 3.68 E-05  32 ± 3 10  
 
Lindane 5.45 E-06  71 ± 4 10 
 
Endosulfan 3.84 E-06  73 ± 3 10  
 
Triclosan 8.0 E-06  32 ± 2 3  
 
Prometryn 1.44 E-05  51 ± 2 10  
 
Terbutryn 1.78 E-05 48 ± 2 10  
 
Terbutylazine 3.34 E-05  32 ± 1 10  
No active Tributyltin, chlorotoluron, metoxuron, chlorosulfuron, nicosulfuron and 
compounds hexachlorobenzene  
 
a, maximal luciferase induction is expressed as a percentage of maximal luciferase activity 
induced by SR12813 at 3 µM (mean value of triplicates ± SD); b, compounds already tested 




Table 2. Summary of hPXR activation by pharmaceuticals in HG5LN-hPXR cells 
 









 3.80 E-07 87 ± 6 3  
compounds Clotrimazole
b












 6.90 E-08  100 ± 5 3  
 
Fenofibrate 1.21 E-06  61 ± 8 3  
 
Tamoxifen 1.26 E-06  39 ± 6 10  
 
Mevastatin 2.39 E -06 80  ± 1 30  
 
Medazepam 4.22 E-06  50  ± 4 10  
 
Diazepam 8.15 E-05  39 ± 3 30  
 
Clonazepam 1.11 E-04  27 ± 1 10  
 
Diclofenac 1.23 E-04  48 ± 1 100 
 
Bezafibrate 2.02 E-04  39 ± 4 100  
 
Carbamazepin 2.72 E-04  40 ± 1 100  
 
Ketoprofene 3.49E-04  30 ± 3 100  
 
Triazolam 3.77E-04  36 ± 1 30  
Inactive loprazolam, bromazepam, alprazolam, naproxen, ibuprofen, aspirin, caffein, 
compounds flumazemil, pravastatin and sulfamethoxazole 
  
 
a, maximal luciferase induction is expressed as a percentage of maximal luciferase activity 
induced by SR12813 at 3 µM (mean value of triplicates ± SD); b, compounds already tested 





Table 3. Summary of hPXR activation by POPs, plasticisers and other compound tested on 
HG5LN-hPXR cells 
 





Concentration at max. 
induction (µM) 
Active PCB 180 1.50 E-05  82 ± 6 30  
compounds PCB 138 1.51 E -05 112 ± 4 30  
 
PCB 153 1.53 E-05  85 ± 11 30  
 
PCB 101 2.06 E-05  74 ± 5 30  
 




 2.71  E-05  37 ± 2 10  
 
TPP 1.36 E-06  62 ± 2 10  
Inactive PCB 28, 52, 77, 126, 169, benzo[k]fluoranthene, 3OH-benzo[a]pyrene, 
compounds fluoranthene, naphtalene and TCDD 
  
 
BHT, DHT, n-butyl paraben, n-benzyl paraben, n-pentyl paraben 
 
a, maximal luciferase induction is expressed as a percentage of maximal luciferase activity 
induced by SR12813 at 3 µM (mean value of triplicates ± SD). b, compound already tested by 










 Concentration (ng/POCIS) 
 
F1 F2 F3 
Pharmaceuticals Carbamazepin 6.0E-04 1.6  0.1 n.d. 
 
Diclofenac 5.4E-04 0.5 3.7 n.d. 




Promethryn 1.0E-02 2 n.d. n.d. 
 
Terbutryn 1.0E-02 1 n.d. n.d. 
 
Lindane 2.7E-02 2 n.d. n.d. 
 
Isoproturon 1.9E-02 6 n.d. n.d. 
 
Linuron 3.1E-03 12 n.d. n.d. 
 
Diuron 1.9E-03 23 n.d. n.d. 
 
o,p’-DDT 1.7E-02 1 n.d. n.d. 
Alkylphenols 4tOP 5.8E-02 10 <1 <1 
 
4NP 3.0E-02 20 <3 <3 
 
BPA 5.8E-03 6 <1 <1 
Hormones E2 3.0E-03 n.d. n.d. 2 
Σ Chem-SR-EQc  (µg/POCIS) 
 
1.5E-03 1.4E-04 1.1E-04 
Bio-SR-EQ
d
  (µg/POCIS) 
 





0.037 0.013 - 
 
a
, SREF: SR12813 equivalence factor relative to SR12813, determined as described in the 
Materials and Methods section. 
b
 n.d.: not detected, 
c 
Chem-SR-EQs: chemical SR12813 
equivalents based on chemical analyses, 
d 
Bio-SR-EQs: biological SR 12813 equivalents 











Site A Site B Site C 
   
 Crude Filtered Crude  Filtered  Crude Filtered 
Pharmaceuticals Carbamazepin 6.8E-04 -
b
 6 - 559 - 248 
 
Diazepam 1.9E-03 - n.d.
c
 - 11 - n.d. 
 
Ketoprofen 4.0E-04 - n.d. - 950 - 303 
 
Diclofenac 5.4E-04 - 27 - 310 - 245 
Hormones E1 4.1E-03 - 83 - 8 - 58 
 
EE2 4.8E-03 - n.d. - 10 - n.d. 
Pesticides Diuron 1.9E-03 - 70 - 430 - 349 
 
Linuron 3.1E-03 - 5 - 294 - 126 
 
Isoproturon 1.8E-03 - 12 - 0.4 - 9 
 
Lindane 2.2E-02 4.5 4 7.3 7 20.5 19 
 
o,p’-DDT 1.8E-02 0.3 n.d. 0.3 0.1 0.3 n.d. 
PCBs PCB 101 3.4E-03 10.8 5.3 3.3 2.3 16 9 
 
PCB 138 5.3E-03 3.2 n.d. 0.7 n.d. 7.5 4 
 
PCB 153 6.0E-03 14 10.2 3.1 2.4 19.4 15 
 
PCB 180 6.1E-03 0.8 n.d. 0.1 n.d. 0.7 n.d. 
Alkylphenols BPA 5.8E-03 6474 5100 232 230 13809 13600 
 
4tOP 6.1E-02 n.d. n.d. 124 124 9 n.d. 
Σ Chem-SR-EQd (µg/L) 
 










0.16 0.13 1.20 1.39 0.86 0.76 
 
a: SREF: SR12813 equivalence factor relative to SR 12813, determined as described in the Materials 
and Methods section. 
b
 - : only analysed in dissolved phase due to hydrophilic properties; c: n.d.: not 
detected or below quantification limits, d: Chem-SR-EQs: chemical SR12813 equivalents, e:
 
Bio-SR-
























Procedural blank n.d. n.d. n.d. n.d. n.d. 
F1 0.44 n.d. n.d. 47.5 n.d 
F2 0.06 n.d. n.d. 15.8 n.d. 
F3 n.d. n.d. n.d. n.d. n.d. 












Procedural blank  n.d. n.d. n.d. n.d n.d. 
A crude 2.2 n.d. n.d. 0.320 n.d. 
 
filtered 2.0 n.d. n.d. 0.107 n.d. 
B crude 1.9 n.d. n.d. 0.453 n.d. 
 
filtered 3.2 n.d. n.d. 0.231 n.d. 
C crude 5.8 8.1 n.d. 0.608 n.d. 
 
filtered 8.2 14.1 n.d. 0.245 n.d. 
LD 0.09 0.98 0.45 0.004 2.7 








Organic extract of 
crude effluent
(0.2 mL methanol)
Organic extract of 
filtered effluent




(0.2 mL methanol) 
Testing for hPXR, ER, (anti)AR and AhR-mediated activities 
using in vitro bioassays
- Liq/liq extraction by 3 50 mL CH2Cl2
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Fig. 7  
